文献速递瓣膜病与结构性心脏病

衰老相关代谢改变加重钙化性主动脉瓣疾病

Senescence-associated metabolic alterations aggravate calcific aortic valve disease.
PubMed 文献 · Eur Heart J · 2026-01-01

该研究结合人主动脉瓣bulk RNA-seq与单细胞转录组,发现衰老瓣膜内皮细胞NAMPT介导的NAD+补救途径抑制最显著,引发炎症衰老;髓系Nampt缺失促钙化,早期NMN补充可减轻钙化,UK Biobank提示血浆NAMPT升高与主动脉瓣狭窄风险相关。

要点

  • 瓣膜内皮细胞NAD+不足是钙化性主动脉瓣疾病起始环节。
  • 髓系NAMPT缺失经FOXA2乙酰化与MMP13促瓣叶钙化。
  • 早期NMN补充可恢复NAD+并减轻瓣膜炎症与钙化。

核心结论

  • 钙化性主动脉瓣疾病由内皮NAD+不足启动,并由代谢异质性巨噬细胞放大。
  • 早期NMN补充及靶向NAMPT干预值得临床评估。

研究设计与样本

  • 结合人主动脉瓣bulk RNA-seq与单细胞转录组绘制NAD+通路。
  • 在杂合、内皮特异性及髓系特异性Nampt敲除小鼠及培养瓣膜内皮细胞与巨噬细胞中测试NAMPT缺失或增益效应。
  • 用早期与晚期烟酰胺单核苷酸补充评估治疗潜力。
  • 用UK Biobank蛋白组学与孟德尔随机化分析循环NAMPT与主动脉瓣狭窄的关联。

主要发现

  • 衰老瓣膜内皮细胞中NAMPT介导的补救途径抑制最显著,触发NAD+耗竭、SIRT1失活及NF-κB超乙酰化,形成ICAM-1富集的炎症衰老表型。
  • 招募的巨噬细胞NAMPT反常上调并分泌胞外NAMPT,经内皮细胞TLR4信号放大瓣膜炎症。
  • 基因组分析显示血浆NAMPT升高与主动脉瓣狭窄风险升高相关。
  • 髓系Nampt缺失产生以FOXA2乙酰化和MMP13驱动胶原破坏为特征的衰老表型,加速瓣叶钙化。
  • 早期烟酰胺单核苷酸治疗恢复瓣膜NAD+、抑制内皮炎症、限制巨噬细胞浸润并减轻钙化,延迟治疗疗效较差。

临床怎么用

  • 早期NAD+补充可能成为钙化性主动脉瓣疾病的候选干预策略。
  • NAMPT及相关NAD+通路可作为药物开发靶点,但需临床评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Calcific aortic valve disease lacks effective pharmacotherapy and is tightly linked to ageing. Since nicotinamide adenine dinucleotide (NAD+) steadily declines with age, this study investigated whether cell-type-specific disruption of NAD+ salvage metabolism drives valvular inflammation and calcification. METHODS: This study combined integrated human aortic-valve bulk RNA-seq with single-cell transcriptomics to map NAD+ pathways. Effects of nicotinamide phosphoribosyltransferase (NAMPT) loss or gain were tested in heterozygous, endothelial-specific, and myeloid-specific Nampt-knockout mice and in cultured valvular endothelial cells and macrophages. Therapeutic potential was evaluated with early vs late nicotinamide mononucleotide supplementation. UK Biobank proteomics and Mendelian randomization examined associations between circulating NAMPT and aortic stenosis. RESULTS: In aged human valves, NAMPT-mediated salvage exhibited the steepest suppression within valvular endothelial cells, triggering NAD+ depletion, SIRT1 inactivation, and hyper-acetylated nuclear factor kappa-B, thereby resulting in an ICAM-1-rich inflammaging profile. Recruited macrophages displayed paradoxical NAMPT up-regulation and secreted extracellular NAMPT that signalled through TLR4 on endothelial cells, amplifying valvular inflammation. Genomic analyses revealed that elevated plasma NAMPT conferred a higher risk of aortic stenosis. On the other side, myeloid Nampt deletion generated a senescent phenotype marked by FOXA2 acetylation and MMP13-driven collagen disruption, accelerating leaflet calcification. Early nicotinamide mononucleotide therapy restored valvular NAD+, dampened endothelial inflammation, limited macrophage infiltration, and attenuated calcification, while delayed treatment was less effective. CONCLUSIONS: Calcific aortic valve disease is initiated by endothelial NAD+ insufficiency and magnified by metabolically diverse macrophages. This compartmentalized NAD+ circuit couples inflammaging to matrix catastrophe. Early NAD+ repletion via nicotinamide mononucleotide and interventions targeting NAMPT warrant clinical evaluation as potential therapies for calcific aortic valve disease.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Qian X, Xu L, Zheng Y, et al. Senescence-associated metabolic alterations aggravate calcific aortic valve disease. Eur Heart J. 2026. PMID: 41841768. doi:10.1093/eurheartj/ehag191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。